News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
690,762 Results
Type
Article (39289)
Company Profile (248)
Press Release (651225)
Section
Business (203976)
Career Advice (2002)
Deals (35396)
Drug Delivery (89)
Drug Development (80909)
Employer Resources (169)
FDA (16120)
Job Trends (14820)
News (344785)
Policy (32464)
Tag
Academia (2530)
Alliances (49285)
Alzheimer's disease (1299)
Approvals (16089)
Artificial intelligence (179)
Bankruptcy (354)
Best Places to Work (11621)
Biotechnology (175)
Breast cancer (214)
Cancer (1588)
Cardiovascular disease (122)
Career advice (1667)
CAR-T (111)
Cell therapy (322)
Clinical research (65043)
Collaboration (606)
Compensation (313)
COVID-19 (2555)
C-suite (141)
Data (1510)
Diabetes (194)
Diagnostics (6233)
Earnings (85127)
Employer resources (146)
Events (110517)
Executive appointments (516)
FDA (16936)
Funding (548)
Gene therapy (223)
GLP-1 (633)
Government (4348)
Healthcare (18741)
Infectious disease (2653)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16421)
Job creations (3626)
Job search strategy (1419)
Layoffs (430)
Legal (7877)
Lung cancer (234)
Manufacturing (221)
Medical device (13244)
Medtech (13249)
Mergers & acquisitions (19281)
Metabolic disorders (513)
Neuroscience (1677)
NextGen: Class of 2025 (6507)
Non-profit (4473)
Northern California (1921)
Obesity (293)
Opinion (188)
Patents (138)
People (56710)
Phase I (20249)
Phase II (28645)
Phase III (21339)
Pipeline (638)
Postmarket research (2562)
Preclinical (8559)
Radiopharmaceuticals (240)
Rare diseases (299)
Real estate (5894)
Regulatory (21829)
Research institute (2311)
Resumes & cover letters (349)
Southern California (1663)
Startups (3567)
United States (17209)
Vaccines (589)
Weight loss (200)
Date
Today (87)
Last 7 days (640)
Last 30 days (2644)
Last 365 days (34726)
2025 (2650)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (206)
Asia (37433)
Australia (6119)
California (4397)
Canada (1603)
China (369)
Colorado (198)
Connecticut (210)
Europe (80183)
Florida (633)
Georgia (154)
Illinois (432)
Indiana (249)
Maryland (697)
Massachusetts (3389)
Michigan (188)
Minnesota (321)
New Jersey (1243)
New York (1266)
North Carolina (798)
Northern California (1921)
Ohio (161)
Pennsylvania (1026)
South America (1093)
Southern California (1663)
Texas (643)
Utah (129)
Washington State (435)
690,762 Results for "skinvisible inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Skinvisible Submits Innovative Obesity Patent for Advanced Transdermal Treatment
Skinvisible Pharmaceuticals, Inc., an innovative pharmaceutical research and development company, announced a major advancement in the battle against obesity.
May 29, 2024
·
4 min read
Skinvisible Expands Obesity Patent Application for Transdermal Delivery
Skinvisible Pharmaceuticals, Inc. (OTCQB:SKVI), an innovative topical / transdermal pharmaceutical research and development company, today announced the filing of a second patent application for its groundbreaking Invisicare® technology and its transdermal delivery of obesity and glucose-controlling agents.
June 24, 2024
·
5 min read
Skinvisible Announces Significant Progress in Licensee’s Clinical Trials for Invisicare Formulation Targeting Nethertons Syndrome
Skinvisible, Inc. (“Skinvisible”) (OTCQB:SKVI) is excited to share a promising update on the ongoing clinical trials conducted by its licensee, Quoin Pharmaceuticals, Inc. (“Quoin”) (NASDAQ:QNRX).
February 14, 2024
·
4 min read
Press Releases
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible
July 12, 2024
·
4 min read
Policy
Skinvisible Announces First Invisicare Delivery Technology Product to Receive U.S. FDA Acceptance of Investigational New Drug
Skinvisible, Inc., is pleased to announce that its licensee Quoin Pharmaceuticals, Inc., has received U.S. FDA acceptance of its Investigational New Drug application for its licensed formulation which uses Skinvisible’s Invisicare® proprietary drug delivery technology.
June 6, 2022
·
3 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
Kronos Advanced Technologies Inc. ($KNOS) Confirms Ownership and Shareholder Updates for KronosMD, Inc.
January 27, 2025
·
13 min read
Press Releases
Telix Completes Acquisition of RLS (USA) Inc.
January 27, 2025
·
8 min read
Press Releases
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
January 29, 2025
·
13 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Execute Agreement for $27 Million Funding Transaction for HOPE Clinic Acquisition
January 28, 2025
·
8 min read
1 of 69,077
Next
